loading page

Exploring the application of copy number variation sequencing in prenatal diagnosis
  • +2
  • Tianyuan Zhang,
  • Suzhen Qu,
  • Zhi Gao,
  • Panlai Shi,
  • Xiangdong Kong
Tianyuan Zhang
Zhengzhou University First Affiliated Hospital
Author Profile
Suzhen Qu
xin yang shi zhong xin yi yuan
Author Profile
Zhi Gao
Zhengzhou University First Affiliated Hospital
Author Profile
Panlai Shi
Zhengzhou University First Affiliated Hospital
Author Profile
Xiangdong Kong
Author Profile

Abstract

Objective: To explore whether CNV-seq can be used as a first-tier diagnostic method or even replace karyotyping for prenatal diagnosis alone. Method: A retrospective study was conducted to 4230 amniocentesis samples with CNV-seq detection and G-banding karyotyping simultaneously. The indications for prenatal diagnosis included abnormal result on Down’s Syndrome Screening, abnormal fetal ultrasound, abnormal result on noninvasive prenatal screening, and so on. The results that lead to birth defects definitely were defined as abnormalities, which included aneuploidy, mosaic aneuploidy, large deletion/duplication and pathogenic copy number variations (pCNVs). Results: 278 cases of abnormalities was identified by karyotyping with an abnormal detection rate of 6.69%(283/4230). In addition, for all the abnormalities identified by karyotyping, CNV-seq also identified another 58 cases of abnormalities. A total of 341 cases of abnormalities were identified by CNV-seq with an abnormal detection rate of 8.06%(341/4230), higher than that of karyotyping. Abnormal detection rate of CNV-seq for the groups with abnormal result on noninvasive prenatal screening, abnormal fetal ultrasound, abnormal parental chromosome, adverse pregnancy history, abnormal result on Down’s Syndrome Screening, volunory testing and advanced maternal age were increased by 2.53%, 1.91%, 1.44%, 1.24%, 1.01%, 0.99% and 0.62% over the karyotyping respectively. Conclusion: CNV-seq and karyotyping had the same effectiveness in identifying aneuploidies, but CNV-seq had absolute superiority in the detection of low proportion of mosaics, imbalanced structural abnormalities. This prevents the birth of fetuses with these chromosome abnormalities that cannot be identified by karyotyping. CNV-seq can replace karyotyping in prenatal diagnosis for chromosome test alone.

Peer review status:POSTED

14 Sep 2020Submitted to BJOG: An International Journal of Obstetrics and Gynaecology
16 Sep 2020Assigned to Editor
16 Sep 2020Submission Checks Completed